Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer: A single center phase II trial.

Wen Zhang,Haitao Zhou,Jun Jiang,Yuelu Zhu,Shuangmei Zou,Yuan Tang,Jianwei Liang,Yongkun Sun,Zhichao Jiang,Zhixiang Zhou,Aiping Zhou

Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer: A single center phase II trial.

2021

Wen Zhang
Haitao Zhou
Jun Jiang
Yuelu Zhu
Shuangmei Zou
Yuan Tang
Jianwei Liang
Yongkun Sun
Zhichao Jiang
Zhixiang Zhou
Aiping Zhou

69Background: Chemoradiotherapy (CRT) remains the standard treatment choice for locally advanced rectal cancer (LARC). Neoadjuvant chemotherapy alone with doublet mFOLFOX6 (folinic acid, 5-fluorour...

Keywords:

Folinic acid
Chemoradiotherapy
Oncology
Medicine
locally advanced
Single Center
Internal medicine
Colorectal cancer
FOLFOXIRI
Chemotherapy
Standard treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations